臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

About TAIR
	About TAIR

Browse By
	Institution
	Author
	Title
	Date
	Statistics Chart
	Institution Facts
	Trend

News
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

Copyright
	Publisher & Journal Policy
	TAIR Copyright Conference Minutes

Related Links
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

"lin c l"

Return to Browse by Author
Sorting by Title	Sort by Date

Showing items 176-225 of 848 (17 Page(s) Totally)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
View [10|25|50] records per page

Institution	Date	Title	Author
臺大學術典藏	2021-10-18T06:51:22Z	Differences in oral habit and lymphocyte subpopulation affect malignant transformation of patients with oral precancer	Yeh C.-Y.; Lin C.-L.; Chang M.-C.; HSIN-MING CHEN; Kok S.-H.; Chang S.-H.; Kuo Y.-S.; Hahn L.-J.; Chan C.-P.; Lee J.-J.; Jeng J.-H.
臺大學術典藏	2021-10-14T02:45:53Z	Increased risk of acute coronary syndrome among patients with urinary stone disease: A nationwide population-based cohort study	Hung S.-F.; CHAO-YUAN HUANG; Lin C.-L.; Chung S.-D.; Chung C.-J.; Kao C.-H.; Chang C.-H.
臺大學術典藏	2021-09-23T03:35:39Z	Renal function-dependent associations of statins with outcomes of ischemic stroke	Yeh S.-J.; SUNG-CHUN TANG; Tsai L.-K.; Chen C.-H.; Hsu S.-P.; Sun Y.; Lien L.-M.; Wei C.-Y.; Lai T.-C.; Chen P.-L.; Chen C.-C.; Huang P.-H.; Lin C.-H.; Liu C.-H.; Lin H.-J.; Hu C.-J.; Lin C.-L.; Jeng J.-S.; Hsu C.Y.; Taiwan Stroke Registry Investigators
臺大學術典藏	2021-09-04T06:19:17Z	Hepatitis B genotypes and precore/basal core promoter mutants in HBeAg-negative chronic hepatitis B	Lin C.-L.; Liao L.-Y.; Liu C.-J.; Chen P.-J.; Lai M.-Y.; JIA-HORNG KAO; Chen D.-S.
臺大學術典藏	2021-09-04T06:19:09Z	Evolution of hepatitis B virus precore/basal core promoter gene in HBeAg-positive chronic hepatitis B patients receiving lamivudine therapy	Lin C.-L.; Liao L.-Y.; Wang C.-S.; Chen P.-J.; Lai M.-Y.; Chen D.-S.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:19:05Z	Basal core-promoter mutant of hepatitis B virus and progression of liver disease in hepatitis B e antigen-negative chronic hepatitis B	Lin C.-L.; Liao L.-Y.; Wang C.-S.; Chen P.-J.; Lai M.-Y.; Chen D.-S.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:19:04Z	Hepatitis B virus genotype and DNA level and hepatocellular carcinoma: A prospective study in men	Yu M.-W.; Yeh S.-H.; Chen P.-J.; Liaw Y.-F.; Lin C.-L.; Liu C.-J.; Shih W.-L.; JIA-HORNG KAO; Chen D.-S.; Chen C.-J.
臺大學術典藏	2021-09-04T06:19:01Z	Application of hepatitis B virus genotyping and phylogenetic analysis in intrafamilial transmission of hepatitis B virus	Lin C.-L.; JIA-HORNG KAO; Chen B.-F.; Chen P.-J.; Lai M.-Y.; Chen D.-S.
臺大學術典藏	2021-09-04T06:18:59Z	Higher cut-off index value of immunoglobulin M antibody to hepatitis B core antigen in Taiwanese patients with hepatitis B	Huang Y.-W.; Lin C.-L.; Chen P.-J.; Lai M.-Y.; JIA-HORNG KAO; Chen D.-S.
臺大學術典藏	2021-09-04T06:18:58Z	Interferon α-2b with and without ribavirin in the treatment of hepatitis B e antigen-positive chronic hepatitis B: A randomized study	Liu C.-J.; Lai M.-Y.; Chao Y.-C.; Liao L.-Y.; Yang S.-S.; Hsiao T.-J.; Hsieh T.-Y.; Lin C.-L.; Hu J.-T.; Chen C.-L.; Chen P.-J.; JIA-HORNG KAO; Chen D.-S.
臺大學術典藏	2021-09-04T06:18:55Z	Intrafamilial transmission of hepatitis B virus infection [3]	Lin C.-L.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:18:55Z	Clinicopathological differences between hepatitis B viral genotype B- and C-related resectable hepatocellular carcinoma	Lin C.-L.; Chen J.-D.; Liu C.-J.; Lee P.-H.; Chen P.-J.; Lai M.-Y.; JIA-HORNG KAO; Chen D.-S.
臺大學術典藏	2021-09-04T06:18:53Z	Association of pre-S deletion mutant of hepatitis B virus with risk of hepatocellular carcinoma	Lin C.-L.; Liu C.-H.; Chen W.; Huang W.-L.; Chen P.-J.; Lai M.-Y.; Chen D.-S.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:18:52Z	Subgenotypes of hepatitis B virus genotype C do not correlate with disease progression of chronic hepatitis B in Taiwan	Tseng T.-C.; Liu C.-J.; Chen P.-J.; Lai M.-Y.; Lin C.-L.; JIA-HORNG KAO; Chen D.-S.
臺大學術典藏	2021-09-04T06:18:52Z	Hepatitis B viral factors in HBeAg-negative carriers with persistently normal serum alanine aminotransferase levels	Lin C.-L.; Liao L.-Y.; Liu C.-J.; Yu M.-W.; Chen P.-J.; Lai M.-Y.; Chen D.-S.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:12:38Z	Hepatitis B viral load as a prognostic factor for patients with unresectable hepatocellular carcinoma	Lin C.-L.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:12:38Z	Reply [2]	Lin C.-L.; Liu C.-J.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:12:34Z	Hepatitis B viral genotype in Taiwanese patients with acute hepatitis B	Huang Y.-W.; Lin C.-L.; Chen P.-J.; Lai M.-Y.; JIA-HORNG KAO; Chen D.-S.
臺大學術典藏	2021-09-04T06:12:32Z	Hepatitis B viral factors and clinical outcomes of chronic hepatitis B	Lin C.-L.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:12:24Z	HBV genotypes and chronicification of acute hepatitis B: More questions than answers	Lin C.-L.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:12:21Z	Optimal management of hepatocellular carcinoma: Challenges and opportunities	Lin C.-L.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:12:20Z	Clinical implications of hepatitis B virus variants	Lin C.-L.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:12:13Z	The clinical implications of hepatitis B virus genotype: Recent advances	Lin C.-L.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:12:11Z	Effect of host and viral factors on hepatitis B e antigen-positive chronic hepatitis B patients receiving pegylated interferon-α-2a therapy	Tseng T.-C.; Yu M.-L.; Liu C.-J.; Lin C.-L.; Huang Y.-W.; Hsu C.-S.; Liu C.-H.; Kuo S.F.-T.; Pan C.J.-H.; Yang S.-S.; Su C.-W.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:12:06Z	Recent advances in the treatment of chronic hepatitis B	Lin C.-L.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:12:01Z	Host genetic variants and hepatitis b virologic features in HBeAg-negative hepatitis B carriers with long-term biochemical remission	Lin C.-L.; Tseng T.-C.; Su T.-H.; Liu C.-J.; Chen P.-J.; Lai M.-Y.; Chen D.-S.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:12:00Z	Interleukin 28B genetic polymorphisms and viral factors help identify HCV genotype-1 patients who benefit from 24-week pegylated interferon plus ribavirin therapy	Liu C.-H.; Liang C.-C.; Liu C.-J.; Tseng T.-C.; Lin C.-L.; Yang S.-S.; Su T.-H.; Hsu S.-J.; Lin J.-W.; Chen J.-H.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:12:00Z	Interleukin 28B genetic polymorphisms play a minor role in identifying optimal treatment duration in HCV genotype 1 slow responders to pegylated interferon plus ribavirin	Liu C.-H.; Liang C.-C.; Liu C.-J.; Tseng T.-C.; Lin C.-L.; Yang S.-S.; Su T.-H.; Lin J.-W.; Chen J.-H.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:11:54Z	Risk stratification for hepatitis B virus related hepatocellular carcinoma	Lin C.-L.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:11:54Z	Viral load and alanine aminotransferase correlate with serologic response in chronic hepatitis B patients treated with entecavir	Wang C.-C.; Tseng K.-C.; Peng C.-Y.; Hsieh T.-Y.; Lin C.-L.; Su T.-H.; Tseng T.-C.; Hsu C.-S.; Lin H.H.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:11:51Z	Sustained hepatitis C virus clearance and increased hepatitis B surface antigen seroclearance in patients with dual chronic hepatitis C and B during posttreatment follow-up	Yu M.-L.; Lee C.-M.; Chen C.-L.; Chuang W.-L.; Lu S.-N.; Liu C.-H.; Wu S.-S.; Liao L.-Y.; Kuo H.-T.; Chao Y.-C.; Tung S.-Y.; Yang S.-S.; JIA-HORNG KAO; Su W.-W.; Lin C.-L.; Yang H.-C.; Chen P.-J.; Chen D.-S.; Liu C.-J.
臺大學術典藏	2021-09-04T06:11:47Z	Hepatitis B virus genotypes: Clinical relevance and therapeutic implications	Lin C.-L.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:11:47Z	Hepatitis B viral factors and treatment responses in chronic hepatitis B	Lin C.-L.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:11:35Z	What can we learn from hepatitis B virus clinical cohorts?	Lin C.-L.; Tseng T.-C.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:11:33Z	Hepatitis B virus genotypes and variants	Lin C.-L.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:11:32Z	Serum biomarkers predictive of significant fibrosis and cirrhosis in chronic hepatitis B	Lin C.-L.; Liu C.-H.; Wang C.-C.; Liang C.-C.; Su T.-H.; Liu C.-J.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:11:31Z	Perspectives and control of hepatitis B virus infection in Taiwan	Lin C.-L.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:11:31Z	Fibrosis index based on four factors better predicts advanced fibrosis or cirrhosis than aspartate aminotransferase/platelet ratio index in chronic hepatitis C patients	Wang C.-C.; Liu C.-H.; Lin C.-L.; Wang P.-C.; Tseng T.-C.; Lin H.H.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:11:28Z	HBV-DNA level at 6 months of entecavir treatment predicts HBeAg loss in HBeAg-positive chronic hepatitis B patients	Peng C.-Y.; Hsieh T.-C.; Hsieh T.-Y.; Tseng K.-C.; Lin C.-L.; Su T.-H.; Tseng T.-C.; Lin H.H.; Wang C.-C.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:11:27Z	Comparison of abbott realtime HCV genotype II with versant line probe assay 2.0 for hepatitis C virus genotyping	Liu C.-H.; Liang C.-C.; Liu C.-J.; Lin C.-L.; Su T.-H.; Yang H.-C.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:11:25Z	Peginterferon plus weight-based ribavirin for treatment-na?ve hepatitis C virus genotype 2 patients not achieving rapid virologic response: A randomized trial	Liu C.-H.; Huang C.-F.; Liu C.-J.; Dai C.-Y.; Huang J.-F.; Lin J.-W.; Liang C.-C.; Yang S.-S.; Lin C.-L.; Su T.-H.; Yang H.-C.; Chen P.-J.; Chen D.-S.; Chuang W.-L.; JIA-HORNG KAO; Yu M.-L.
臺大學術典藏	2021-09-04T06:11:22Z	Peginterferon alfa-2a plus Weight-Based or Flat-Dose Ribavirin for Treatment-Na?ve Hepatitis C Virus Genotype 2 Rapid Responders: A Randomized Trial	Liu C.-H.; Huang C.-F.; Liu C.-J.; Dai C.-Y.; Huang J.-F.; Lin J.-W.; Liang C.-C.; Yang S.-S.; Lin C.-L.; Su T.-H.; Yang H.-C.; Chen P.-J.; Chen D.-S.; Chuang W.-L.; JIA-HORNG KAO; Yu M.-L.
臺大學術典藏	2021-09-04T06:11:21Z	Hepatitis B virus: New therapeutic perspectives	Lin C.-L.; Yang H.-C.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:11:21Z	Can noninvasive biomarkers replace liver biopsy for chronic hepatitis B?	Lin C.-L.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:11:19Z	New perspectives of biomarkers for the management of chronic hepatitis B	Lin C.-L.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:11:18Z	Efficacy and resistance to telbivudine treatment in chronic hepatitis B patients with favorable predictors: a multicenter study in Taiwan	Wang C.-C.; Lin C.-L.; Hsieh T.-Y.; Tseng K.-C.; Peng C.-Y.; Su T.-H.; Yang S.-S.; Hsu Y.-C.; Chen T.-M.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:11:15Z	Efficacy of entecavir therapy for hepatitis B e-antigen positive chronic hepatitis B patients with prior exposure to interferon or nucleoside/nucleotide analogues	Tseng K.-C.; Tseng C.-W.; Hsieh T.-Y.; Peng C.-Y.; Lin C.-L.; Su T.-H.; Tseng T.-C.; Lin H.H.; Wang C.-C.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:11:14Z	Review article: novel therapies for hepatitis B virus cure – advances and perspectives	Lin C.-L.; JIA-HORNG KAO
臺大學術典藏	2021-09-04T06:11:08Z	Four-year entecavir therapy reduces hepatocellular carcinoma, cirrhotic events and mortality in chronic hepatitis B patients	Su T.-H.; Hu T.-H.; Chen C.-Y.; Huang Y.-H.; Chuang W.-L.; Lin C.-C.; Wang C.-C.; Su W.-W.; Chen M.-Y.; Peng C.-Y.; Chien R.-N.; Huang Y.-W.; Wang H.-Y.; Lin C.-L.; Yang S.-S.; Chen T.-M.; Mo L.-R.; Hsu S.-J.; Tseng K.-C.; Hsieh T.-Y.; Suk F.-M.; Hu C.-T.; Bair M.-J.; Liang C.-C.; Lei Y.-C.; Tseng T.-C.; Chen C.-L.; JIA-HORNG KAO; the C-TEAM study group; the Taiwan Liver Diseases Consortium
臺大學術典藏	2021-09-04T06:11:07Z	Hepatitis B reactivation in patients receiving immunosuppressive therapy: a hidden menace	Lin C.-L.; JIA-HORNG KAO

Showing items 176-225 of 848 (17 Page(s) Totally)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
View [10|25|50] records per page

	English \| 正體中文 \| 简体中文 \| Total items :0
	Visitors : 52293892 Online Users : 654 Project Commissioned by the Ministry of Education Project Executed by National Taiwan University Library